Asia Pacific Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation

July 2011 | 358 pages | ID: AED6BF6EE6FEN
iData Research Inc.

Abstracts

The Asia-Pacific orthopedic biomaterials market is expected to approach $1.6 billion by 2017. The hyaluronic acid viscosupplementation segment is expected to constitute the majority of the Asia-Pacific orthopedic biomaterials market.

The Asia-Pacific orthopedic biomaterials report covers the following countries:

• Japan
• South Korea
• Australia
• China

The segments covered in this report include:

• autologous bone grafts,
• bone graft substitutes (BGS; segmented into allografts, demineralized bone matrices and synthetics),
• hyaluronic acid (HA) viscosupplementation,
• bone morphogenetic protein (BMP) growth factor therapy
• autologous chondrocyte implantation (ACI)

The market is approaching maturity, but is expected to continue to grow as a result of the aging Asia-Pacific population. BMP growth factor therapy was the fastest growing segment in 2010, increasing almost 7% over the previous year.

This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

The executive summary of this report is also available for purchase.

Contents

EXECUTIVE SUMMARY

1.1 TOTAL ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET
1.2 HERFINDAHL INDEX COUNTRY PROFILES
1.3 GROWTH TRENDS BY MARKET SEGMENT
1.4 BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS
1.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
1.6 BONE MORPHOGENETIC PROTEIN MARKET
1.7 COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
  2.2.1 Step 1: Project Initiation & Team Selection
  2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
  2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
  2.2.4 Step 4: Performing Primary Research
  2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
  2.2.6 Step 6: Market Forecast and Analysis
  2.2.7 Step 7: Identify Strategic Opportunities
  2.2.8 Step 8: Final Review and Market Release
  2.2.9 Step 9: Customer Feedback and Market Monitoring

ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET

3.1 INTRODUCTION
  3.1.1 Growth Factors
  3.1.2 Bone Graft Substitutes
  3.1.3 Hyaluronic Acid Viscosupplementation
3.2 CURRENCY EXCHANGE RATES
3.3 MARKET OVERVIEW
3.4 MARKET BY SEGMENT
3.5 TREND ANALYSIS BY SEGMENT
3.6 MARKET BY COUNTRY
  3.6.1 Total Market
  3.6.2 Japan
  3.6.3 China
  3.6.4 South Korea
  3.6.5 Australia
3.7 MARKET DRIVERS AND LIMITERS
  3.7.1 Market Drivers
  3.7.2 Market Limiters
3.8 COMPETITIVE ANALYSIS
  3.8.1 Herfindahl Index
3.9 MERGERS AND ACQUISITIONS

COUNTRY PROFILES

4.1 INTRODUCTION
  4.1.1 Population
  4.1.2 GDP per Capita
  4.1.3 Price Index
4.2 JAPAN
4.3 CHINA
4.4 SOUTH KOREA
4.5 AUSTRALIA

PROCEDURE NUMBERS

5.1 OVERVIEW
  5.1.1 Total Orthopedic Bone Graft Substitute Procedures by Indication
  5.1.2 Total Orthopedic Bone Graft Substitute Procedures by Segment
  5.1.3 Total Orthopedic Bone Graft Substitute Procedures by Country

BONE GRAFT SUBSTITUTE MARKET

6.1 INTRODUCTION
  6.1.1 Volumes Represented per Procedure
6.2 JAPAN
  6.2.1 Market Analysis and Forecast
    6.2.1.1 Volumes Represented per Procedure
    6.2.1.2 Total Synthetic Market
    6.2.1.3 Synthetic Spine Market
    6.2.1.4 Synthetic Cervical Spine Market
    6.2.1.5 Synthetic Thoracolumbar Spine Market
    6.2.1.6 Synthetic Trauma and Reconstruction Market
    6.2.1.7 Synthetic Craniomaxillofacial Market
  6.2.2 Market Drivers and Limiters
    6.2.2.1 Market Drivers
    6.2.2.2 Market Limiters
  6.2.3 Competitive Analysis
6.3 CHINA
  6.3.1 Overview
  6.3.2 Market Analysis and Forecast
    6.3.2.1 Total Allograft Market
    6.3.2.2 Allograft Spine Market
    6.3.2.3 Allograft Cervical Spine Market
    6.3.2.4 Allograft Thoracolumbar Spine Market
    6.3.2.5 Allograft Trauma & Reconstruction Market
    6.3.2.6 Allograft Craniomaxillofacial Market
    6.3.2.7 Total Synthetic Market
    6.3.2.8 Synthetic Spine Market
    6.3.2.9 Synthetic Cervical Spine Market
    6.3.2.10 Synthetic Thoracolumbar Spine Market
    6.3.2.11 Synthetic Trauma & Reconstruction Market
    6.3.2.12 Synthetic Craniomaxillofacial Market
    6.3.2.13 Total DBM Market
    6.3.2.14 DBM Spine Market
    6.3.2.15 DBM Cervical Spine Market
    6.3.2.16 DBM Thoracolumbar Spine Market
    6.3.2.17 DBM Trauma & Reconstruction Market
    6.3.2.18 DBM Craniomaxillofacial Market
  6.3.3 Market Drivers and Limiters
    6.3.3.1 Market Drivers
    6.3.3.2 Market Limiters
  6.3.4 Competitive Analysis
6.4 SOUTH KOREA
  6.4.1 Overview
  6.4.2 Market Analysis and Forecast
    6.4.2.1 Total Allograft Market
    6.4.2.2 Allograft Spine Market
    6.4.2.3 Allograft Cervical Spine Market
    6.4.2.4 Allograft Thoracolumbar Spine Market
    6.4.2.5 Allograft Trauma & Reconstruction Market
    6.4.2.6 Allograft Craniomaxillofacial Market
    6.4.2.7 Total Synthetic Market
    6.4.2.8 Synthetic Spine Market
    6.4.2.9 Synthetic Cervical Spine Market
    6.4.2.10 Synthetic Thoracolumbar Spine Market
    6.4.2.11 Synthetic Trauma & Reconstruction Market
    6.4.2.12 Synthetic Craniomaxillofacial Market
    6.4.2.13 Total Demineralized Bone Matrix Market
    6.4.2.14 DBM Spine Market
    6.4.2.15 DBM Cervical Spine Market
    6.4.2.16 DBM Thoracolumbar Spine Market
    6.4.2.17 DBM Trauma & Reconstruction Market
    6.4.2.18 DBM Craniomaxillofacial Market
  6.4.3 Market Drivers and Limiters
    6.4.3.1 Market Drivers
    6.4.3.2 Market Limiters
  6.4.4 Competitive Analysis
6.5 AUSTRALIA
  6.5.1 Overview
  6.5.2 Market Analysis and Forecast
    6.5.2.1 Total Allograft Market
    6.5.2.2 Allograft Spine Market
    6.5.2.3 Allograft Cervical Spine Market
    6.5.2.4 Allograft Thoracolumbar Spine Market
    6.5.2.5 Allograft Trauma & Reconstruction Market
    6.5.2.6 Allograft Craniomaxillofacial Market
    6.5.2.7 Total Synthetic Market
    6.5.2.8 Synthetic Spine Market
    6.5.2.9 Synthetic Cervical Spine Market
    6.5.2.10 Synthetic Thoracolumbar Spine Market
    6.5.2.11 Synthetic Trauma & Reconstruction Market
    6.5.2.12 Synthetic Craniomaxillofacial Market
  6.5.3 Market Drivers and Limiters
    6.5.3.1 Market Drivers
    6.5.3.2 Market Limiters
  6.5.4 Competitive Analysis

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

7.1 INTRODUCTION
  7.1.1 Overview
  7.1.2 Potential Complications
7.2 AUSTRALIA
  7.2.1 Market Analysis and Forecast
    7.2.1.1 Total BMP Market
  7.2.2 Market Drivers and Limiters
    7.2.2.1 Market Drivers
    7.2.2.2 Market Limiters
  7.2.3 Competitive Analysis

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

8.1 INTRODUCTION
    8.1.1.1 Single-Injection Products
    8.1.1.2 Three-Injection Cycle Products
    8.1.1.3 Five-Injection Cycle Products
8.2 JAPAN
  8.2.1 Market Analysis and Forecast
    8.2.1.1 Total Hyaluronic Acid Viscosupplementation Market
  8.2.2 Market Drivers and Limiters
    8.2.2.1 Market Drivers
    8.2.2.2 Market Limiters
  8.2.3 Competitive Analysis
8.3 CHINA
  8.3.1 Market Analysis and Forecast
    8.3.1.1 Total Hyaluronic Acid Viscosupplementation Market
  8.3.2 Market Analysis and Forecast
    8.3.2.1 Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market
    8.3.2.2 Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market
  8.3.3 Market Drivers and Limiters
    8.3.3.1 Market Drivers
    8.3.3.2 Market Limiters
  8.3.4 Competitive Analysis
8.4 SOUTH KOREA
  8.4.1 Overview
  8.4.2 Market Analysis and Forecast
    8.4.2.1 Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market
    8.4.2.2 Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market
  8.4.3 Market Drivers and Limiters
    8.4.3.1 Market Drivers
    8.4.3.2 Market Limiters
  8.4.4 Competitive Analysis
8.5 AUSTRALIA
  8.5.1 Market Analysis and Forecast
  8.5.2 Market Drivers and Limiters
    8.5.2.1 Market Drivers
    8.5.2.2 Market Limiters
  8.5.3 Competitive Analysis

ABBREVIATIONS

APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BY WEIGHT

APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

APPENDIX 3: EMERGING MARKETS

12.1 BONE MORPHOGENETIC PROTEIN MARKET
12.2 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

List Of Figures

LIST OF FIGURES

EXECUTIVE SUMMARY
Figure 1-1: Total Orthopedic Biomaterials Market, Asia-Pacific, 2010 (US$M)
Figure 1-2: Herfindahl Index by Country, Asia-Pacific, 2010
Figure 1-3: Growth Trends, Orthopedic Biomaterials Market, Asia-Pacific, 2007 – 2017
Figure 1-4: Procedure Numbers, Bone Graft Substitute Market, Asia-Pacific, 2007 – 2017
Figure 1-5: Growth Rates, Hyaluronic Acid Viscosupplementation Market, Asia-Pacific, 2007 – 2017
Figure 1-6: Bone Morphogenetic Protein Market, Australia, 2007 – 2017 (US$M) .
Figure 1-7: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific, 2010
RESEARCH METHODOLOGY
ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET
Figure 3-1: Exchange Rate for Currencies, 2010
Figure 3-2: Orthopedic Biomaterials Market, Asia-Pacific, 2007 – 2017
Figure 3-3: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2007 – 2017 (US$M)
Figure 3-4: Growth Rates by Segment, Orthopedic Biomaterials Market, Asia-Pacific, 2007 – 2017
Figure 3-5: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2007 – 2017 (US$M)
Figure 3-6: Orthopedic Biomaterials Market by Segment, Japan, 2007 – 2017 (US$M)
Figure 3-7: Orthopedic Biomaterials Market by Segment, Japan, 2007 – 2017 (JP?M)
Figure 3-8: Orthopedic Biomaterials Market by Segment, China, 2007 – 2017 (US$M)
Figure 3-9: Orthopedic Biomaterials Market by Segment, China, 2007 – 2017 (CN?M)
Figure 3-10: Orthopedic Biomaterials Market by Segment, South Korea, 2007 – 2017 (US$M)
Figure 3-11: Orthopedic Biomaterials Market by Segment, South Korea, 2007 – 2017 (KR?M)
Figure 3-12: Orthopedic Biomaterials Market by Segment, Australia, 2007 – 2017 (US$M)
Figure 3-13: Orthopedic Biomaterials Market by Segment, Australia, 2007 – 2017 (AU$M)
Figure 3-14: Drivers and Limiters, Orthopedic Biomaterials Market, Asia-Pacific, 2010
Figure 3-15: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific, 2010 (1 of 2)
Figure 3-16: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific, 2010 (2 of 2)
Figure 3-17: H-Index, Orthopedic Biomaterials Market, Asia-Pacific, 2010
COUNTRY PROFILES
Figure 4-1: Country Indicators, Asia-Pacific, 2010
PROCEDURE NUMBERS
Figure 5-1: Total Bone Graft Substitute Procedures by Indication, Asia-Pacific, 2007 – 2017
Figure 5-2: Total Orthopedic Bone Graft Substitute Procedures by Segment, Asia-Pacific, 2007 – 2017
Figure 5-3: Total Orthopedic Bone Graft Substitute Procedures by Country, Asia-Pacific, 2007 – 2017
BONE GRAFT SUBSTITUTE MARKET
Figure 6-1: Total Synthetic Market, Japan, 2007 – 2017 (US$)
Figure 6-2: Total Synthetic Market, Japan, 2007 – 2017 (JP?)
Figure 6-3: Synthetic Total Spine Market, Japan, 2007 – 2017 (US$)
Figure 6-4: Synthetic Total Spine Market, Japan, 2007 – 2017 (JP?)
Figure 6-5: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (US$)
Figure 6-6: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (JP?)
Figure 6-7: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017 (US$)
Figure 6-8: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017 (JP?)
Figure 6-9: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017 (US$)
Figure 6-10: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017 (JP?)
Figure 6-11: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (US$).
Figure 6-12: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (JP?)
Figure 6-13: Drivers and Limiters, Bone Graft Substitute Market, Japan, 2010 .
Figure 6-14: Leading Competitors, Bone Graft Substitute Market, Japan, 2010 .
Figure 6-15: Bone Graft Substitute Market by Segment, China, 2007 – 2017 (US$M)
Figure 6-16: Bone Graft Substitute Market by Segment, China, 2007 – 2017 (CN?M)
Figure 6-17: Total Allograft Market, China, 2007 – 2017 (US$)
Figure 6-18: Total Allograft Market, China, 2007 – 2017 (CN?)
Figure 6-19: Allograft Total Spine Market, China, 2007 – 2017 (US$)
Figure 6-20: Allograft Total Spine Market, China, 2007 – 2017 (CN?)
Figure 6-21: Allograft Cervical Spine Market, China, 2007 – 2017 (US$)
Figure 6-22: Allograft Cervical Spine Market, China, 2007 – 2017 (CN?)
Figure 6-23: Allograft Thoracolumbar Spine Market, China, 2007 – 2017 (US$)
Figure 6-24: Allograft Thoracolumbar Spine Market, China, 2007 – 2017 (CN?)
Figure 6-25: Allograft Trauma & Reconstruction Market, China, 2007 – 2017 (US$)
Figure 6-26: Allograft Trauma & Reconstruction Market, China, 2007 – 2017 (CN?)
Figure 6-27: Allograft Craniomaxillofacial Market, China, 2007 – 2017 (US$)
Figure 6-28: Allograft Craniomaxillofacial Market, China, 2007 – 2017 (CN?)
Figure 6-29: Total Synthetic Market, China, 2007 – 2017 (US$)
Figure 6-30: Total Synthetic Market, China, 2007 – 2017 (CN?)
Figure 6-31: Synthetic Total Spine Market, China, 2007 – 2017 (US$)
Figure 6-32: Synthetic Total Spine Market, China, 2007 – 2017 (CN?)
Figure 6-33: Synthetic Cervical Spine Market, China, 2007 – 2017 (US$)
Figure 6-34: Synthetic Cervical Spine Market, China, 2007 – 2017 (CN?)
Figure 6-35: Synthetic Thoracolumbar Spine Market, China, 2007 – 2017 (US$)
Figure 6-36: Synthetic Thoracolumbar Spine Market, China, 2007 – 2017 (CN?)
Figure 6-37: Synthetic Trauma & Reconstruction Market, China, 2007 – 2017 (US$)
Figure 6-38: Synthetic Trauma & Reconstruction Market, China, 2007 – 2017 (CN?)
Figure 6-39: Synthetic Craniomaxillofacial Market, China, 2007 – 2017 (US$)
Figure 6-40: Synthetic Craniomaxillofacial Market, China, 2007 – 2017 (CN?)
Figure 6-41: Total DBM Market, China, 2007 – 2017 (US$)
Figure 6-42: Total DBM Market, China, 2007 – 2017 (CN?)
Figure 6-43: DBM Total Spine Market, China, 2007 – 2017 (US$)
Figure 6-44: DBM Total Spine Market, China, 2007 – 2017 (CN?)
Figure 6-45: DBM Cervical Spine Market, China, 2007 – 2017 (US$)
Figure 6-46: DBM Cervical Spine Market, China, 2007 – 2017 (CN?)
Figure 6-47: DBM Thoracolumbar Spine Market, China, 2007 – 2017 (US$)
Figure 6-48: DBM Thoracolumbar Spine Market, China, 2007 – 2017 (CN?)
Figure 6-49: DBM Trauma & Reconstruction Market, China, 2007 – 2017 (US$)
Figure 6-50: DBM Trauma & Reconstruction Market, China, 2007 – 2017 (CN?)
Figure 6-51: DBM Craniomaxillofacial Market, China, 2007 – 2017 (US$)
Figure 6-52: DBM Craniomaxillofacial Market, China, 2007 – 2017 (CN?)
Figure 6-53: Drivers and Limiters, Bone Graft Substitute Market, China, 2010
Figure 6-54: Leading Competitors, Bone Graft Substitute Market, China, 2010
Figure 6-55: Bone Graft Substitute Market by Segment, South Korea, 2007 – 2017 (US$M)
Figure 6-56: Bone Graft Substitute Market by Segment, South Korea, 2007 – 2017 (KR?M)
Figure 6-57: Total Allograft Market, South Korea, 2007 – 2017 (US$)
Figure 6-58: Total Allograft Market, South Korea, 2007 – 2017 (KR?)
Figure 6-59: Allograft Total Spine Market, South Korea, 2007 – 2017 (US$)
Figure 6-60: Allograft Total Spine Market, South Korea, 2007 – 2017 (KR?)
Figure 6-61: Allograft Cervical Spine Market, South Korea, 2007 – 2017 (US$)
Figure 6-62: Allograft Cervical Spine Market, South Korea, 2007 – 2017 (KR?)
Figure 6-63: Allograft Thoracolumbar Spine Market, South Korea, 2007 – 2017 (US$)
Figure 6-64: Allograft Thoracolumbar Spine Market, South Korea, 2007 – 2017 (KR?)
Figure 6-65: Allograft Trauma & Reconstruction Market, South Korea, 2007 – 2017 (US$)
Figure 6-66: Allograft Trauma & Reconstruction Market, South Korea, 2007 – 2017 (KR?)
Figure 6-67: Allograft Craniomaxillofacial Market, South Korea, 2007 – 2017 (US$)
Figure 6-68: Allograft Craniomaxillofacial Market, South Korea, 2007 – 2017 (KR?)
Figure 6-69: Total Synthetic Market, South Korea, 2007 – 2017 (US$)
Figure 6-70: Total Synthetic Market, South Korea, 2007 – 2017 (KR?)
Figure 6-71: Synthetic Total Spine Market, South Korea, 2007 – 2017 (US$)
Figure 6-72: Synthetic Total Spine Market, South Korea, 2007 – 2017 (KR?)
Figure 6-73: Synthetic Cervical Spine Market, South Korea, 2007 – 2017 (US$)
Figure 6-74: Synthetic Cervical Spine Market, South Korea, 2007 – 2017 (KR?)
Figure 6-75: Synthetic Thoracolumbar Spine Market, South Korea, 2007 – 2017 (US$)
Figure 6-76: Synthetic Thoracolumbar Spine Market, South Korea, 2007 – 2017 (KR?)
Figure 6-77: Synthetic Trauma & Reconstruction Market, South Korea, 2007 – 2017 (US$)
Figure 6-78: Synthetic Trauma & Reconstruction Market, South Korea, 2007 – 2017 (KR?)
Figure 6-79: Synthetic Craniomaxillofacial Market, South Korea, 2007 – 2017 (US$)
Figure 6-80: Synthetic Craniomaxillofacial Market, South Korea, 2007 – 2017 (KR?)
Figure 6-81: Total DBM Market, South Korea, 2007 – 2017 (US$)
Figure 6-82: Total DBM Market, South Korea, 2007 – 2017 (KR?)
Figure 6-83: DBM Total Spine Market, South Korea, 2007 – 2017 (US$)
Figure 6-84: DBM Total Spine Market, South Korea, 2007 – 2017 (KR?)
Figure 6-85: DBM Cervical Spine Market, South Korea, 2007 – 2017 (US$)
Figure 6-86: DBM Cervical Spine Market, South Korea, 2007 – 2017 (KR?)
Figure 6-87: DBM Thoracolumbar Spine Market, South Korea, 2007 – 2017 (US$)
Figure 6-88: DBM Thoracolumbar Spine Market, South Korea, 2007 – 2017 (KR?)
Figure 6-89: DBM Trauma & Reconstruction Market, South Korea, 2007 – 2017 (US$)
Figure 6-90: DBM Trauma & Reconstruction Market, South Korea, 2007 – 2017 (KR?)
Figure 6-91: DBM Craniomaxillofacial Market, South Korea, 2007 – 2017 (US$)
Figure 6-92: DBM Craniomaxillofacial Market, South Korea, 2007 – 2017 (KR?)
Figure 6-93: Drivers and Limiters, Bone Graft Substitute Market, South Korea, 2010
Figure 6-94: Leading Competitors, Bone Graft Substitute Market, South Korea, 2010
Figure 6-95: Bone Graft Substitute Market by Segment, Australia, 2007 – 2017 (US$M)
Figure 6-96: Bone Graft Substitute Market by Segment, Australia, 2007 – 2017 (AU$M)
Figure 6-97: Total Allograft Market, Australia, 2007 – 2017 (US$)
Figure 6-98: Total Allograft Market, Australia, 2007 – 2017 (AU$)
Figure 6-99: Allograft Total Spine Market, Australia, 2007 – 2017 (US$)
Figure 6-100: Allograft Total Spine Market, Australia, 2007 – 2017 (AU$)
Figure 6-101: Allograft Cervical Spine Market, Australia, 2007 – 2017 (US$)
Figure 6-102: Allograft Cervical Spine Market, Australia, 2007 – 2017 (AU$)
Figure 6-103: Allograft Thoracolumbar Spine Market, Australia, 2007 – 2017 (US$)
Figure 6-104: Allograft Thoracolumbar Spine Market, Australia, 2007 – 2017 (AU$)
Figure 6-105: Allograft Trauma & Reconstruction Market, Australia, 2007 – 2017 (US$)
Figure 6-106: Allograft Trauma & Reconstruction Market, Australia, 2007 – 2017 (AU$)
Figure 6-107: Allograft Craniomaxillofacial Market, Australia, 2007 – 2017 (US$)
Figure 6-108: Allograft Craniomaxillofacial Market, Australia, 2007 – 2017 (AU$)
Figure 6-109: Total Synthetic Market, Australia, 2007 – 2017 (US$)
Figure 6-110: Total Synthetic Market, Australia, 2007 – 2017 (AU$)
Figure 6-111: Synthetic Total Spine Market, Australia, 2007 – 2017 (US$)
Figure 6-112: Synthetic Total Spine Market, Australia, 2007 – 2017 (AU$)
Figure 6-113: Synthetic Cervical Spine Market, Australia, 2007 – 2017 (US$)
Figure 6-114: Synthetic Cervical Spine Market, Australia, 2007 – 2017 (AU$)
Figure 6-115: Synthetic Thoracolumbar Spine Market, Australia, 2007 – 2017 (US$)
Figure 6-116: Synthetic Thoracolumbar Spine Market, Australia, 2007 – 2017 (AU$)
Figure 6-117: Synthetic Trauma & Reconstruction Market, Australia, 2007 – 2017 (US$)
Figure 6-118: Synthetic Trauma & Reconstruction Market, Australia, 2007 – 2017 (AU$)
Figure 6-119: Synthetic Craniomaxillofacial Market, Australia, 2007 – 2017 (US$)
Figure 6-120: Synthetic Craniomaxillofacial Market, Australia, 2007 – 2017 (AU$)
Figure 6-121: Drivers and Limiters, Bone Graft Substitute Market, Australia, 2010
Figure 6-122: Leading Competitors, Bone Graft Substitute Market, Australia, 2010
Figure 6-123: Leading Competitors, Bone Graft Substitute Market, Australia, 2010
BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET
Figure 7-1: Bone Morphogenetic Market, Australia, 2007 – 2017 (US$)
Figure 7-2: Bone Morphogenetic Market, Australia, 2007 – 2017 (AU$)
Figure 7-3: Drivers and Limiters, Bone Morphogenetic Protein Market, Australia, 2010
Figure 7-4: Leading Competitors, Bone Morphogenetic Protein Market, Australia, 2010
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
Figure 8-1: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 – 2017 (US$)
Figure 8-2: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 – 2017 (JP?)
Figure 8-3: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, Japan, 2010
Figure 8-4: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Japan, 2010
Figure 8-5: Total Hyaluronic Acid Viscosupplementation Market,
Figure 8-6: Total Hyaluronic Acid Viscosupplementation Market, China, 2007 – 2017 (CN?M)
Figure 8-7: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 – 2017 (US$)
Figure 8-8: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 – 2017 (CN?)
Figure 8-9: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 – 2017 (US$)
Figure 8-10: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 – 2017 (CN?)
Figure 8-11: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, China, 2010
Figure 8-12: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2010
Figure 8-13: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 – 2017 (US$M)
Figure 8-14: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 – 2017 (KR?M)
Figure 8-15: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 – 2017 (US$)
Figure 8-16: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 – 2017 (KR?)
Figure 8-17: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 – 2017 (US$)
Figure 8-18: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 – 2017 (KR?)
Figure 8-19: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, South Korea, 2010
Figure 8-20: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, South Korea, 2010
Figure 8-21: Hyaluronic Acid Viscosupplementation Market, Australia, 2007 – 2017 (US$)
Figure 8-22: Hyaluronic Acid Viscosupplementation Market, Australia, 2007 – 2017 (AU$)
Figure 8-23: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, Australia, 2010
Figure 8-24: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Australia, 2010
ABBREVIATIONS
APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BY WEIGHT
Figure 10-1: Total Synthetic Market, Japan, 2007 – 2017 (US$)
Figure 10-2: Total Synthetic Market, Japan, 2007 – 2017 (JP?)
Figure 10-3: Synthetic Total Spine Market, Japan, 2007 – 2017 (US$)
Figure 10-4: Synthetic Total Spine Market, Japan, 2007 – 2017 (JP?)
Figure 10-5: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (US$)
Figure 10-6: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (JP?)
Figure 10-7: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017 (US$)
Figure 10-8: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017 (JP?)
Figure 10-9: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017 (US$)
Figure 10-10: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017 (JP?)
Figure 10-11: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (US$)
Figure 10-12: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (JP?)
APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
Figure 11-1: Exchange Rate for Currencies, 2010
Figure 11-2: Hyaluronic Acid Viscosupplementation Market, Taiwan, 2007 – 2017 (US$)
Figure 11-3: Hyaluronic Acid Viscosupplementation Market, Taiwan, 2007 – 2017 (TW$)
APPENDIX 3: EMERGING MARKETS

LIST OF CHART'S

EXECUTIVE SUMMARY
RESEARCH METHODOLOGY
ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET
Chart 3-1: Orthopedic Biomaterials Market, Asia-Pacific, 2007 – 2017 (US$M)
Chart 3-2: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2007 – 2017 (US$M)
Chart 3-3: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2010
Chart 3-4: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2017
Chart 3-5: Growth Rates by Segment, Orthopedic Biomaterials Market, Asia-Pacific, 2007 – 2017
Chart 3-6: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2007 – 2017 (US$M)
Chart 3-7: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2010
Chart 3-8: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2017
Chart 3-9: Orthopedic Biomaterials Market by Segment, Japan, 2007 – 2017 (US$M)
Chart 3-10: Orthopedic Biomaterials Market by Segment, Japan, 2010
Chart 3-11: Orthopedic Biomaterials Market by Segment, Japan, 2017
Chart 3-12: Orthopedic Biomaterials Market by Segment, China, 2007 – 2017 (US$M)
Chart 3-13: Orthopedic Biomaterials Market by Segment, China, 2010
Chart 3-14: Orthopedic Biomaterials Market by Segment, China, 2017
Chart 3-15: Orthopedic Biomaterials Market by Segment, South Korea, 2007 – 2017 (US$M)
Chart 3-16: Orthopedic Biomaterials Market by Segment, South Korea, 2010
Chart 3-17: Orthopedic Biomaterials Market by Segment, South Korea, 2017
Chart 3-18: Orthopedic Biomaterials Market by Segment, Australia, 2007 – 2017 (US$M)
Chart 3-19: Orthopedic Biomaterials Market by Segment, Australia, 2010
Chart 3-20: Orthopedic Biomaterials Market by Segment, Australia, 2017
Chart 3-21: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific, 2010
Chart 3-22: H-Index, Orthopedic Biomaterials Market, Asia-Pacific, 2010
COUNTRY PROFILES
Chart 4-1: Country Profile, Japan, 2010
Chart 4-2: Country Profile, China, 2010
Chart 4-3: Country Profile, South Korea, 2010
Chart 4-4: Country Profile, Australia, 2010
PROCEDURE NUMBERS
Chart 5-1: Orthopedic Bone Graft Substitute Procedures by Indication, Asia-Pacific, 2010
Chart 5-2: Orthopedic Bone Graft Substitute Procedures by Indication, Asia-Pacific, 2017
Chart 5-3: Total Orthopedic Bone Graft Substitute Procedures by Segment, Asia-Pacific, 2010
Chart 5-4: Total Orthopedic Bone Graft Substitute Procedures by Segment, Asia-Pacific, 2017
Chart 5-5: Total Orthopedic Bone Graft Substitute Procedures by Country, Asia-Pacific, 2010
Chart 5-6: Total Orthopedic Bone Graft Substitute Procedures by Country, Asia-Pacific, 2017
BONE GRAFT SUBSTITUTE MARKET
Chart 6-1: Total Synthetic Market, Japan, 2007 – 2017 (US$M)
Chart 6-2: Synthetic Total Spine Market, Japan, 2007 – 2017 (US$M)
Chart 6-3: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (US$M)
Chart 6-4: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017 (US$M)
Chart 6-5: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017 (US$M)
Chart 6-6: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (US$M)
Chart 6-7: Leading Competitors, Bone Graft Substitute Market, Japan, 2010
Chart 6-8: Bone Graft Substitute Market by Segment, China, 2007 – 2017 (US$M)
Chart 6-9: Bone Graft Substitute Market by Segment, China, 2010
Chart 6-10: Bone Graft Substitute Market by Segment, China, 2017
Chart 6-11: Total Allograft Market, China, 2007 – 2017 (US$M)
Chart 6-12: Allograft Total Spine Market, China, 2007 – 2017 (US$M)
Chart 6-13: Allograft Cervical Spine Market, China, 2007 – 2017 (US$M)
Chart 6-14: Allograft Thoracolumbar Spine Market, China, 2007 – 2017 (US$M)
Chart 6-15: Allograft Trauma & Reconstruction Market, China, 2007 – 2017 (US$M)
Chart 6-16: Allograft Craniomaxillofacial Market, China, 2007 – 2017 (US$M)
Chart 6-17: Total Synthetic Market, China, 2007 – 2017 (US$M)
Chart 6-18: Synthetic Total Spine Market, China, 2007 – 2017 (US$M)
Chart 6-19: Synthetic Cervical Spine Market, China, 2007 – 2017 (US$M)
Chart 6-20: Synthetic Thoracolumbar Spine Market, China, 2007 – 2017 (US$M)
Chart 6-21: Synthetic Trauma & Reconstruction Market, China, 2007 – 2017 (US$M)
Chart 6-22: Synthetic Craniomaxillofacial Market, China, 2007 – 2017 (US$M)
Chart 6-23: Total DBM Market, China, 2007 – 2017 (US$M)
Chart 6-24: DBM Total Spine Market, China, 2007 – 2017 (US$M)
Chart 6-25: DBM Cervical Spine Market, China, 2007 – 2017 (US$M)
Chart 6-26: DBM Thoracolumbar Spine Market, China, 2007 – 2017 (US$M)
Chart 6-27: DBM Trauma & Reconstruction Market, China, 2007 – 2017 (US$M)
Chart 6-28: DBM Craniomaxillofacial Market, China, 2007 – 2017 (US$M)
Chart 6-29: Leading Competitors, Bone Graft Substitute Market, China, 2010
Chart 6-30: Bone Graft Substitute Market by Segment, South Korea, 2007 – 2017 (US$M)
Chart 6-31: Bone Graft Substitute Market by Segment, South Korea, 2010
Chart 6-32: Bone Graft Substitute Market by Segment, South Korea, 2017
Chart 6-33: Total Allograft Market, South Korea, 2007 – 2017 (US$M)
Chart 6-34: Allograft Total Spine Market, South Korea, 2007 – 2017 (US$M)
Chart 6-35: Allograft Cervical Spine Market, South Korea, 2007 – 2017 (US$M)
Chart 6-36: Allograft Thoracolumbar Spine Market, South Korea, 2007 – 2017 (US$M)
Chart 6-37: Allograft Trauma & Reconstruction Market, South Korea, 2007 – 2017 (US$M)
Chart 6-38: Allograft Craniomaxillofacial Market, South Korea, 2007 – 2017 (US$M)
Chart 6-39: Total Synthetic Market, South Korea, 2007 – 2017 (US$M)
Chart 6-40: Synthetic Total Spine Market, South Korea, 2007 – 2017 (US$M)
Chart 6-41: Synthetic Cervical Spine Market, South Korea, 2007 – 2017 (US$M)
Chart 6-42: Synthetic Thoracolumbar Spine Market, South Korea, 2007 – 2017 (US$M)
Chart 6-43: Synthetic Trauma & Reconstruction Market, South Korea, 2007 – 2017 (US$M)
Chart 6-44: Synthetic Craniomaxillofacial Market, South Korea, 2007 – 2017 (US$M)
Chart 6-45: Total DBM Market, South Korea, 2007 – 2017 (US$M)
Chart 6-46: DBM Total Spine Market, South Korea, 2007 – 2017 (US$M)
Chart 6-47: DBM Cervical Spine Market, South Korea, 2007 – 2017 (US$M)
Chart 6-48: DBM Thoracolumbar Spine Market, South Korea, 2007 – 2017 (US$M)
Chart 6-49: DBM Trauma & Reconstruction Market, South Korea, 2007 – 2017 (US$M)
Chart 6-50: DBM Craniomaxillofacial Market, South Korea, 2007 – 2017 (US$M)
Chart 6-51: Leading Competitors, Bone Graft Substitute Market, South Korea, 2010
Chart 6-52: Bone Graft Substitute Market by Segment, Australia, 2007 – 2017 (US$M)
Chart 6-53:Bone Graft Substitute Market by Segment, Australia, 2010
Chart 6-54: Bone Graft Substitute Market by Segment, Australia, 2017
Chart 6-55: Total Allograft Market, Australia, 2007 – 2017 (US$M)
Chart 6-56: Allograft Total Spine Market, Australia, 2007 – 2017 (US$M)
Chart 6-57: Allograft Cervical Spine Market, Australia, 2007 – 2017 (US$M)
Chart 6-58: Allograft Thoracolumbar Spine Market, Australia, 2007 – 2017 (US$M)
Chart 6-59: Allograft Trauma & Reconstruction Market, Australia, 2007 – 2017 (US$M)
Chart 6-60: Allograft Craniomaxillofacial Market, Australia, 2007 – 2017 (US$M)
Chart 6-61: Total Synthetic Market, Australia, 2007 – 2017 (US$M)
Chart 6-62: Synthetic Total Spine Market, Australia, 2007 – 2017 (US$M)
Chart 6-63: Synthetic Cervical Spine Market, Australia, 2007 – 2017 (US$M)
Chart 6-64: Synthetic Thoracolumbar Spine Market, Australia, 2007 – 2017 (US$M)
Chart 6-65: Synthetic Trauma & Reconstruction Market, Australia, 2007 – 2017 (US$M)
Chart 6-66: Synthetic Craniomaxillofacial Market, Australia, 2007 – 2017 (US$M)
BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET
Chart 7-1: Bone Morphogenetic Market, Australia, 2007 – 2017 (US$M)
Chart 7-2: Leading Competitors, Bone Morphogenetic Protein Market, Australia, 2010
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
Chart 8-1: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 – 2017 (US$M)
Chart 8-2: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Japan, 2010
Chart 8-3: Total Hyaluronic Acid Viscosupplementation Market, China, 2007 – 2017 (US$M)
Chart 8-4: Total Hyaluronic Acid Viscosupplementation Market, China, 2010
Chart 8-5: Total Hyaluronic Acid Viscosupplementation Market, China, 2017
Chart 8-6: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 – 2017 (US$M)
Chart 8-7: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 – 2017 (US$M)
Chart 8-8: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2010
Chart 8-9: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 – 2017 (US$M)
Chart 8-10: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2010
Chart 8-11: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2017
Chart 8-12: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 – 2017 (US$M)
Chart 8-13: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 – 2017 (US$M)
Chart 8-14: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, South Korea, 2010
Chart 8-15: Hyaluronic Acid Viscosupplementation Market, Australia, 2010 – 2017 (US$M)
Chart 8-16: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Australia, 2010
ABBREVIATIONS
APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BY WEIGHT
APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
Chart 11-1: Hyaluronic Acid Viscosupplementation Market, Taiwan, 2007 – 2017 (US$M)
APPENDIX 3: EMERGING MARKETS